Delivery Order SPE2DB22D3010-SPE2DB25FP2CC
Award Date
4/4/25
Potential Completion Date
4/7/25
Potential Value
$5.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with the ID SPE2DB20D1102|SPE2DB25FC5YH, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567073984 - VALSARTAN-HCTZ 320-25 MG TAB 90S, with a ceiling value of $3,030.79 and a performance period ending on January 29, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,351.98 firm fixed-price delivery order contract is for the supply of VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication. The contract has an ultimate completion date of April 9, 2025 and was awarded on April 8, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award, valued at $5,893.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALSARTAN-HCTZ 320-12.5 MG TAB 90S, a cardiovascular medication, with a completion date of January 13, 2025. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This contract award, with ID SPE2DB20D3303|SPE2DB25FZ4E1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,293.24, is for the delivery of VALSARTAN-HCTZ 80-12.5 MG TAB 90S, a cardiovascular medication. It is a Firm Fixed Price Delivery Order contract with a period of performance through March 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,486.93, is for the supply of VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,644.01, is a Firm Fixed Price Delivery Order for the supply of VALSARTAN-HCTZ 80-12.5 MG TAB 90S, a cardiovascular medication. The contract has an ultimate completion date of February 28, 2025 and was awarded on February 27, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $22,603.51, is for the delivery of VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 6, 2025. The contract is not designated with any set-aside requirements, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a pharmaceutical product, with a ceiling value of $8,594.99. The contract is a firm fixed price Delivery Order with a period of performance extending through May 20, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,912.99, is for the delivery of 4567626817 VALSARTAN-HCTZ 320-25 MG TAB 90S. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 20, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a significant...
This federal contract award, identified as SPE2DB20D2104|SPE2DB24FR84Z, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-HCTZ 320-25 mg tablets, with an ultimate completion date of January 2, 2024 and a ceiling value of $2,150.51. The contract is a delivery order, with a firm fixed price pricing type. It is not designated with a set-aside...